Sterile compounding is one of the most regulated areas in pharmacy practice. Whether you're preparing IV medications, ophthalmic solutions, or injectable compounds, compliance with USP 797 and USP 800 standards isn't optional — it's essential for patient safety and your pharmacy's license.
The 2023 revisions to USP 797 brought significant changes that many pharmacies are still working to implement. This guide breaks down what you need to know and how to build a compliance system that works.
Understanding USP 797: The Foundation of Sterile Compounding
USP Chapter 797 establishes the minimum standards for compounding sterile preparations (CSPs). The goal is simple: prevent patient harm from contaminated, improperly prepared, or incorrectly stored sterile medications.
The chapter covers everything from facility design to personnel training, and applies to all healthcare settings where sterile compounding occurs — hospital pharmacies, compounding pharmacies, physician offices, and outpatient surgical centers.
Key USP 797 Requirements
Facility Design and Environmental Controls: Your compounding area must meet specific ISO classifications. Primary engineering controls (PECs) like laminar airflow workbenches or isolators must be located in appropriate secondary engineering controls (SECs) — buffer rooms and ante-rooms with proper HEPA filtration and pressure differentials.
Beyond-Use Dating (BUD): The 2023 revision introduced new categories based on risk assessment rather than the old low/medium/high risk system. BUD assignments now depend on whether compounding occurs in an SCA (segregated compounding area) or classified cleanroom suite, along with the sterility testing performed.
Personnel Training and Competency: Staff must complete initial training and demonstrate ongoing competency through media fill testing and gloved fingertip sampling. Documentation of this training is critical during inspections.
Environmental Monitoring: Regular monitoring of viable and non-viable particles in your compounding environment is required. This includes surface sampling, air sampling, and temperature/humidity logging.
USP 800: Handling Hazardous Drugs Safely
While USP 797 covers sterile compounding in general, USP Chapter 800 specifically addresses hazardous drugs (HDs) — medications that pose risks to healthcare workers who handle them. This includes many chemotherapy agents, certain antivirals, and hormone preparations.
What Makes USP 800 Different
Worker Protection Focus: Unlike USP 797's patient-centric approach, USP 800 prioritizes protecting pharmacy staff from exposure through appropriate containment, PPE, and handling procedures.
Negative Pressure Requirements: HD compounding must occur in a negative pressure room relative to surrounding areas, preventing contaminated air from escaping. This is the opposite of typical sterile compounding environments.
Decontamination Procedures: Specific cleaning and decontamination protocols are required for all surfaces that may contact hazardous drugs, with documentation of each cleaning session.
Spill Management: Detailed spill kits and procedures must be readily available, with staff trained on proper response protocols.
Key Compliance Point
USP 800 applies to ALL handling of hazardous drugs — not just compounding. Receiving, storage, dispensing, and disposal all fall under its requirements. Many pharmacies underestimate the scope of compliance needed.
Documentation Requirements That Matter
Both USP 797 and USP 800 require extensive documentation. During a board inspection, your records tell the story of your compliance. Missing or incomplete documentation is one of the most common citation triggers.
Essential Records to Maintain
- Temperature and humidity logs — monitored continuously or at minimum twice daily for all storage and compounding areas
- Environmental monitoring results — viable and non-viable sampling data with trend analysis
- Cleaning and disinfection logs — who cleaned what, when, and with which agents
- Personnel training records — initial competency assessments and ongoing evaluations
- Media fill test results — documented for each compounding staff member
- Equipment maintenance and certification — HEPA filter testing, hood certification, pressure monitoring
- Master formulation records — complete compounding instructions for each preparation
- Compounding records — batch documentation for every preparation made
Environmental Monitoring: Your Early Warning System
Environmental monitoring isn't just a compliance checkbox — it's how you catch problems before they become patient safety issues. A contamination event detected through monitoring allows you to take corrective action before any compromised preparations reach patients.
Monitoring Frequency Guidelines
Temperature and Humidity: Continuous monitoring is ideal, but at minimum, document readings twice daily. Out-of-range conditions should trigger immediate investigation and corrective action documentation.
Pressure Differentials: Verify that positive or negative pressure relationships between rooms are maintained. Document readings at the start of each compounding shift.
Viable Air Sampling: Required during dynamic compounding conditions. Frequency depends on your risk assessment but typically monthly for cleanroom suites.
Surface Sampling: Regular sampling of work surfaces, walls, and floors in compounding areas. Document locations, methods, and results.
How Digital Tools Transform Compliance
Paper-based compliance systems for sterile compounding are increasingly difficult to maintain. The documentation requirements are extensive, and paper logs are prone to errors, illegibility, and gaps that create inspection headaches.
Digital checklist systems like Miratag's pharmacy compliance solution address these challenges directly:
- Scheduled reminders ensure temperature checks and environmental monitoring happen on time, every time
- Automatic timestamps create tamper-proof documentation of when tasks were completed and by whom
- Out-of-range alerts notify supervisors immediately when readings fall outside acceptable limits
- Photo documentation captures visual evidence of cleaning completion and equipment setup
- Trend reporting identifies patterns that might indicate emerging problems
- Instant audit access — pull any record from any date in seconds during an inspection
Building Your Compliance Program
Effective sterile compounding compliance isn't about perfect execution on inspection day — it's about systems that ensure consistent performance every day. Here's how to build that foundation:
- Conduct a gap assessment — Compare your current practices against USP 797 and USP 800 requirements. Identify where you're compliant and where improvements are needed.
- Prioritize critical gaps — Focus first on issues that pose patient safety risks or would result in serious inspection citations.
- Develop standard operating procedures — Document every process in detail. SOPs should be specific enough that any trained staff member can follow them.
- Implement daily checklists — Convert your SOPs into actionable checklists that staff complete during each shift.
- Train and document — Ensure every staff member understands their compliance responsibilities. Keep detailed training records.
- Monitor and improve — Review your compliance data regularly. Use trends to identify areas for improvement before they become problems.
Pro Tip
Schedule a mock inspection annually. Have someone not involved in daily compounding review your documentation and practices with fresh eyes. The issues they find are the same ones a board inspector will catch.
Common Compliance Pitfalls
Inconsistent documentation: Temperature logs with gaps, cleaning records that skip days, training documentation that expires without renewal — inconsistency suggests a program that's not truly followed.
Outdated SOPs: Your procedures should reflect current practice. If your written SOPs don't match what staff actually do, that's a red flag for inspectors.
Inadequate garbing procedures: Proper donning sequence, garb quality, and hand hygiene are frequently cited areas. Ensure your protocols meet USP requirements and are followed consistently.
Missing corrective actions: When monitoring reveals out-of-range conditions, there must be documented investigation and corrective action. Finding the problem is only half the requirement.
Overlooking HD handling outside compounding: USP 800 covers the entire HD lifecycle. Many pharmacies focus on compounding but neglect receiving, storage, and disposal compliance.
Preparing for Inspections
Board inspections shouldn't be stressful if your compliance program is solid. Inspectors are looking for evidence that you have systems in place and that those systems are consistently followed.
Keep these documents readily accessible:
- Current SOPs for all compounding operations
- Personnel training and competency records
- Environmental monitoring data and trend reports
- Equipment maintenance and certification records
- Cleaning and disinfection logs
- Temperature and humidity records
- Compounding records and master formulations
With a digital system, you can retrieve any of these records in seconds. That responsiveness demonstrates organization and builds inspector confidence in your program.
Moving Forward
USP 797 and USP 800 compliance is complex, but it's manageable with the right systems. The key is building processes that make compliance the default — not something that requires extra effort.
Digital checklists, automated monitoring, and systematic documentation transform compliance from a burden into a natural part of daily operations. When compliance is built into your workflow, inspections become opportunities to showcase your program rather than stressful audits to survive.
Ready to streamline your pharmacy's sterile compounding compliance? Contact our team to learn how Miratag helps pharmacies maintain continuous compliance with less effort. Or explore our pharmacy solutions to see how we can help.